<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>EFFICACY OF CORTEXIN IN PATIENTS WITH TRAUMATIC BRAIN DISEASE COMPLICATED BY INTRACEREBRAL HEMATOMAS</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">M.A. Artikova</mods:namePart><mods:namePart type="family">M.A. Artikova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">N.D. Salokhitdinova</mods:namePart><mods:namePart type="family">N.D. Salokhitdinova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">J.A. Nazarova</mods:namePart><mods:namePart type="family">J.A. Nazarova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>When treating victims with TBM accompanied by traumatic intracranial hemorrhage, one should also take into account factors of secondary brain damage, which are not directly related to the mechanism of its primary damage, but always affect the course of the post-traumatic period and the prognosis of outcome. Prevention of complications largely depends on understanding the mechanisms and nature of brain damage (1,2,3).</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-04-29</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>